Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Gastroenterology,Hepatology
Link
http://www.nature.com/articles/ajg201160.pdf
Reference49 articles.
1. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohns disease: the CLASSIC-I trial.;Hanauer;Gastroenterology,2006
2. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.;Sandborn;Ann Intern Med,2007
3. Adalimumab for maintenance of clinical response and remission in patients with Crohns disease: the CHARM trial.;Colombel;Gastroenterology,2007
4. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohns disease: results from the CHARM trial.;Colombel;Am J Gastroenterol,2009
5. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.;Clark;Gastroenterology,2007
Cited by 364 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn’s Disease in the Phase 2 AMAG Study;Inflammatory Bowel Diseases;2024-08-02
2. The economic impact of suboptimal treatment and treatment switch among patients with Crohn’s disease treated with a first-line biologic – A US retrospective claims database study;Journal of Medical Economics;2024-07-16
3. Sex and age differences in inflammatory bowel disease patients; a nationwide study based on Iranian Registry of Crohn’s and Colitis (IRCC);PLOS ONE;2024-07-11
4. Impact of a Patient Support Program on time to discontinuation of adalimumab in Australian adult patients with immune-mediated inflammatory diseases–an observational study;PLOS ONE;2024-06-13
5. Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn’s Disease;Journal of Crohn's and Colitis;2024-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3